Scopolamine Challenge Study

NCT01213355 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: Scopolamine
DRUG: PF-05212377
DRUG: Scopolamine
DRUG: PF-05212377
DRUG: scopolamine
DRUG: PF-05212377
DRUG: scopolamine
DRUG: Donepezil
DRUG: Scopolamine

Sponsor

Pfizer